BLCO Stock Recent News

Bausch + Lomb offers a variety of lenses that provide a competitive advantage for every type of consumer. The long-term outlook looks bright due to the strong catalysts, but the short-term outlook is mixed due to the IPO lock-up date.

The U.S. IPO market is ice cold following a hot 2021. One May IPO, Bausch + Lomb, is a household name with high uncertainty regarding a planned spinoff and a key drug.

Bausch + Lomb Corporation (NYSE:BLCO ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Arthur Shannon - Investor Relations Joseph Papa - Chief Executive Officer Sam Eldessouky - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi Craig Bijou - Bank of America Imron Zafar - Deutsche Bank Doug Miehm - RBC Capital Markets Yatin Suneja - Guggenheim Partners Cecilia Furlong - Morgan Stanley Vijay Kumar - Evercore Zack Weiner - Jefferies Operator Good morning, and welcome to the Bausch + Lomb's Second Quarter 2022 Earnings Call. All participants will be in a listen-only mode.